A recent study published in BMC Neuroscience highlights psilocybin’s potential neuroprotective effects.
Conducted by researchers from Taiwan National Health Research Institutes, China Medical University, and University Hospitals of Cleveland, the study explored how psilocybin—a 5HT2A receptor agonist found in “magic mushrooms”—can reduce brain damage and enhance neurological recovery after stroke.
The study involved adult male and pregnant Sprague-Dawley rats, which were subjected simulated stroke conditions. Psilocybin was administered either before or shortly after the induced stroke.
Continue reading